Alzheimers Disease and other Cognitive Disorders
Basic Information
Introduction & Causes of Cognitive DisordersDementiaAlzheimer's DiseaseOther Cognitive DisordersDementia Coping Skills & Behavior ManagementTraumatic Brain Injury (TBI)Conclusion and Resources
More InformationLatest News
Pro Soccer Players More Likely to Develop Dementia: StudyDrug Limits Damage of Brain InjuryYour Personality as a Teen May Predict Your Risk of DementiaWhat Helps Calm Agitated Dementia Patients?AHA News: Growing – and Aging – Hispanic Population at Risk for DementiaAHA News: Yo-Yoing Blood Pressure Could Be Bad for Those With Alzheimer'sGive Seniors a Memory Check at Annual Checkups, Experts SayFor People at High Risk, Evidence That Exercise Might Slow Alzheimer'sDementia Caregivers Often Face Sleepless NightsHealth Tip: Dementia and DrivingGetting Hitched Might Lower Your Odds for DementiaHow You Can Help Head Off Alzheimer's DiseaseDeep Brain 'Zap' Restores Vivid Memories to Alzheimer's PatientsHow to Protect a Loved One With Dementia During a Heat WaveToo Much Napping May Signal Alzheimer'sDepression, Alzheimer's Might Be Part of Same Process in Some Aging Brains: StudyStay Social to Help Cut Your Odds of DementiaBlood Test May Spot Brain Changes of Early Alzheimer'sClues to Why Women Have Higher Odds for Alzheimer'sA New and Better Way to 'Stage' Alzheimer's Patients?At Risk for Alzheimer's? Exercise Might Help Keep It at BayHealthy Living Can Cut Odds for Alzheimer's in People at Genetic RiskHormone Treatment for Prostate Cancer Linked to Heightened Alzheimer's RiskAlzheimer's Genes Might Show Effects in Your 20sWidely Prescribed Class of Meds Might Raise Dementia RiskCancer Survivors May Have Lower Odds for DementiaCommon Blood Pressure Med Might Help Fight Alzheimer'sEducation, Intelligence Might Protect Your BrainFor Some, Trouble Tracking Finances Could Be Sign of DementiaIt's Never Too Late for New Brain CellsHigh LDL Cholesterol Tied to Early-Onset Alzheimer'sDoes Hormone Therapy for Prostate Cancer Raise Dementia Risk?Could Alzheimer's Spread Like Infection Throughout the Brain?Newly Discovered Illness May Cause Nearly 1 in 5 Dementias, Experts SayFinancial Scammers Often Prey on People With Early DementiaMore Alzheimer's Drug Trial Failures: Are Researchers on the Wrong Track?Gum Disease Shows Possible Links to Alzheimer'sBrain Scans Spot, Track Alzheimer'sFewer Periods May Mean Higher Dementia RiskOnly Spoken Words Processed in Newly Discovered Brain RegionRate of U.S. Deaths Tied to Dementia Has More Than DoubledEven Distant Relatives' History Could Up Your Alzheimer's RiskDementia May Strike Differently, Depending on RaceHormone Therapy Linked to Slight Rise in Alzheimer's RiskSleep Apnea May Be Linked With Alzheimer's MarkerScientists Find 5 New Genes That Sway Alzheimer's RiskAre Hearing Loss, Mental Decline Related?Education No Match Against Alzheimer'sCould Gut Bacteria Be Linked to Dementia Risk?Plunging Temperatures a Threat to People With Alzheimer's
Questions and AnswersVideosLinksBook Reviews
Related Topics

Aging & Geriatrics
Memory Problems
Elder Care

Can Alzheimer's Be Spread? Mouse Study Hints It's Possible

HealthDay News
by By Dennis Thompson
HealthDay Reporter
Updated: Dec 13th 2018

new article illustration

THURSDAY, Dec. 13, 2018 (HealthDay News) -- A brain protein linked to Alzheimer's disease might potentially be transmitted to people during neurological procedures, a new preliminary study suggests.

Genetically engineered lab mice developed amyloid-beta deposits in their brains after they were injected with amyloid-laced samples of human growth hormone taken from decades-old human cadavers, researchers found.

"We have now provided experimental evidence to support our hypothesis that amyloid-beta pathology can be transmitted to people from contaminated materials," said senior researcher Dr. John Collinge. He is head of University College London's department of neurodegenerative disease.

Clumps of amyloid-beta in the brain are a hallmark of Alzheimer's disease, although researchers still don't understand the relationship between these clumps and the degenerative brain disease.

Collinge pointedly noted that this study does not mean that you can catch Alzheimer's from another person. And animal findings often don't replicate in humans.

"Although we're generating evidence that Alzheimer's pathology may be transmissible, there's absolutely no suggestion that Alzheimer's disease itself is a contagious disease," he said.

Rebecca Edelmayer, director of scientific engagement at the Alzheimer's Association, went even further, noting that the new study did not look at Alzheimer's disease at all.

"They're looking at a buildup of amyloid in the brain, which is not the same thing as Alzheimer's," Edelmayer said.

"This is very, very preliminary research," she added. "It's very interesting, but preliminary."

The mouse study is the latest chapter in a decades-long saga involving contaminated cadaver-derived human growth hormone (c-HGH).

Between 1958 and 1985, about 30,000 children with growth deficiencies were treated with human growth hormone drawn from the pituitary glands of corpses, scientists explained in an editorial accompanying the new study.

In 1985, three of these children were diagnosed with Creutzfeldt-Jakob disease (CJD), a fatal illness that causes progressive and irreversible brain damage.

The use of cadaver-derived HGH was subsequently abandoned. Doctors now prescribe a synthetic form of human growth hormone.

Overall, more than 200 people treated with c-HGH worldwide have died of CJD, the researchers said.

In 2015, Collinge and his colleagues reported that these c-HGH injections appeared to have "seeded" amyloid-beta into the brains of at least some of the patients.

Amyloid-beta deposits were found in six out of eight autopsied brains of people who died of CJD after receiving injections of c-HGH, the researchers noted.

In the latest study, his team wanted to make sure c-HGH was the true culprit behind the amyloid-beta deposits. So, they tracked down some of the original batches with which patients had been treated and tested them. The investigators found that some of the samples did have significant levels of amyloid-beta proteins.

The scientists then injected the tainted c-HGH into lab mice that had been genetically engineered to process the protein in the same way as humans.

"I was rather amazed we could seed so easily from this material, which had sat around at room temperature as a dry powder for 30 or 40 years," Collinge said. "It showed the persistence of these seeds to degradation."

The findings were published Dec. 13 in the journal Nature.

Collinge said his main concern from these findings is the potential of contaminated surgical equipment to transfer amyloid-beta between people.

"I think any risk from that would likely be small. I certainly wouldn't want to discourage anybody from having neurosurgery," Collinge said. "We need to develop new means of removing these seeds from instruments so any small risk that is there is removed, and we prevent any transmission by that route."

The potential risk of amyloid-beta transmission through blood transfusion also should be re-examined, he said, although it's not cause for alarm.

"People have looked at that in the past and have not found any association between blood transfusion and Alzheimer's disease, but I think it wouldn't be unreasonable to do further studies in that regard," Collinge said.

"I think transfusion is probably not a major concern for me," he continued. "I can't absolutely rule it out, but I think it's unlikely to be much of a problem. I'm more concerned about neurosurgical instruments and making sure we clean those thoroughly."

More information

The U.S. Centers for Disease Control and Prevention has more about Creutzfeldt-Jakob disease.


Amazon Smile

To quit smoking, call Connecticut QuitLine at 1-800-QUIT-NOW.

Children and Adult services are available now with no wait time.  Please contact HBH Intake Department at 860-548-0101, option 2.


powered by centersite dot net